E-Rare, the ERA-Net for Research Programmes on Rare Diseases, announced its 10th joint call for "Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases".

EU-OPENSCREEN warmly welcomes consortia bidding for the E-Rare call to come and discuss how our respective organisations might cooperate. Please email us at office@eu-openscreen.eu for more information. The transnational research proposals must cover at least one of the following areas, which are equal in relevance for this call:

-Combined multi-omics approaches (e.g. epigenomics, transcriptomics, metabolomics, proteomics, etc.) that complement genomics-based gene discovery strategies and that are driven by a lead hypothesis

- Functional validation of clinical or biological inferences obtained from “-omics” results

- Application of “-omics” approaches to rare diseases for which the gene(s) is/are known to enable insight into disease pathophysiology

- Development and application of concepts and methods for pathogenic read-outs of disease groups, which can be used as "blue print" to discover new disease genes and inform pathomechanism.

For detailed information about E-Rare's 10th joint call, please see here. For information on E-Rare, please visit www.e-rare.eu.